RxDoctor Payments Data

Imtiaz Qureshi, MD

Internal Medicine · Orlando, FLNPI 1689687980

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AstraZeneca at 29.8% of the total. Reporting peaked in 2023 at $1,516 and has fallen 56.8% since, to $654 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,989in general payments, 2019–2025

Across 280 payments — averaging $24.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Bayer$765
  • Novo Nordisk$679
  • GSK$599
  • Boehringer Ingelheim$520
  • Lilly USA, LLC$401
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$6,983100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,989 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$38,229
Medicare patients
183
Services billed
412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium16$108
Atorvastatin Calcium15$84
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$81
Methocarbamol14$65
Prednisone12$33
Amlodipine Besylate15$30

Paid to pharmacies, not to this prescriber.

Other internal medicine in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →